A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Neuralgia, Postherpetic

In brief

This is a safety and efficacy study of AGN-214868 in patients with postherpetic neuralgia (PHN).

Key facts

Study ID

NCT01678924

Run by

Allergan

People needed

280

Starts

2013-01-01

Expected to finish

2015-09-01

Last updated by the study team

2020-01-07

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Postherpetic neuralgia with pain present for at least 9 months

You may not qualify if…

• Active herpes zoster skin rash
• Anticipated treatment for postherpetic neuralgia during the first 3 months of the study, including oral and topical medications, acupuncture, spinal cord stimulation, transcutaneous nerve stimulation (TNS), or trigger point injection
• Anticipated treatment with pain medication for the treatment of postherpetic neuralgia during the first 3 months of the study
• Use of capsaicin treatment for postherpetic neuralgia within 6 months, or anticipated use during the first 3 months of the study
• Use of botulinum toxin of any serotype for any reason within 6 months, or anticipated use during the study

Where it is running

• Territory Neurology & Research Institute — Tucson, Arizona, United States
• Neuro-Pain Medical Center — Fresno, California, United States
• University of California, Irvine — Irvine, California, United States
• Loma Linda University — Loma Linda, California, United States
• Northern California Research Corp — Sacramento, California, United States
• Neurological Research Institute — Santa Monica, California, United States
• Alpine Clinical Research Center — Boulder, Colorado, United States
• The Mile High Research Center — Denver, Colorado, United States
• Riverside Clinical Research — Edgewater, Florida, United States
• Compass Research, LLC — Orlando, Florida, United States
• Drug Studies America — Marietta, Georgia, United States
• Injury Care Research, LLC — Boise, Idaho, United States
• Millennium Pain Center — Bloomington, Illinois, United States
• Beacon Clinical Research — Brockton, Massachusetts, United States
• Springfield Neurology Associates, LLC — Springfield, Massachusetts, United States
• Michigan Head Pain and Neurology Institute — Ann Arbor, Michigan, United States
• Quest Research Institute — Farmington Hills, Michigan, United States
• Center for Pharmaceutical Research — Kansas City, Missouri, United States
• Clinvest Headache Care Center — Springfield, Missouri, United States
• Albuquerque Neuroscience, Inc. — Albuquerque, New Mexico, United States
• The Medical Research Network, LLC — New York, New York, United States
• Island Neurological Associates, P.C. — Plainview, New York, United States
• Wake Research Associates — Raleigh, North Carolina, United States
• Plains Medical Clinic — Fargo, North Dakota, United States
• Agave Clinical Research, LLC — Mesa, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.